Abstract:The design and development of contrast agents for magnetic resonance imaging (MRI) with improved chemical stability and higher contrasting capability for clinical translation compared to conventional contrast agents are still of great interest. In this study, a facile and universal approach was explored for controllable functionalization of red-emissive carbon nanodots (RCNDs) with diethylenetriaminepentaacetic anhydride (DTPA) for chelation of gadolinium. A series of accurate characterizations were used to control each step of the synthesis. The functionalization did not alter the band gap of the carbon nanodots, preserving their inherent far-red fluorescence. The as-prepared RCND-DTPA-Gd displayed a high colloidal stability with negligible Gd leakage. The nanodots also showed a better magnetic resonance relaxivity than commercial MRI agents. RCND-DTPA-Gd had good biocompatibility <i>in vivo</i> even at high doses. The systemically injected RCND-DTPA-Gd were found to be efficiently excreted through the renal route, a feature that further minimizes the potential toxicity risks. All these properties suggest that carbon nanodots can be well designed as efficient carriers of Gd, resulting in potential clinical tools as dual MRI/fluorescence functional probes for imaging applications. The approach described here could pave the pathway to a flexible strategy for the controllable functionalization of small-sized nanoparticles including carbon dots, rendering them more versatile. This work is expected to promote the future translation of carbon nanodots into clinical trials.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsanm.0c02993?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsanm.0c02993</a>.Organ distribution of RCND-DTPA-Gd in vivo (Videos S1 and S2) (<a class="ext-link" href="/doi/suppl/10.1021/acsanm.0c02993/suppl_file/an0c02993_si_001.zip">ZIP</a>)Synthesis of DTPA ligand (Scheme S1), additional HAADF-STEM images of the RCND-DTPA-Gd sample (Figure S1), DLS of RCND-DTPA-Gd (Figure S2), FL spectra of CND-DTPA-Gd (Figure S3), cell viability of RCND-DTPA-Gd (Figure S4), and the hematological and biochemical parameters of RCND-DTPA (Tables S1 and S2) (<a class="ext-link" href="/doi/suppl/10.1021/acsanm.0c02993/suppl_file/an0c02993_si_002.pdf">PDF</a>)This article has not yet been cited by other publications.

A Positively Charged Small-Molecule T1 Magnetic Resonance Imaging Contrast Agent for Highly Efficient Labeling and Tracking Adipose Tissue-Derived Stem Cells

Magnetic Resonance Imaging of Iron Oxide-Labeled Human Embryonic Stem Cell-Derived Cardiac Progenitors.

Labeling Neural Stem Cells with Superparamagnetic Iron Oxide and MRI Tracking in Vitro and in Vivo

In Vivo MRI Tracking of Bone Mesenchymal Stem Cell Viability with a T1-T2 Switchable Contrast Agent

Stem Cell Labeling With Superparamagnetic Iron Oxide Nanoparticles Using Focused Ultrasound And Magnetic Resonance Imaging Tracking

Magnetic Labeling and Tracking of Cells Using Magnetodendrimers As MR Contrast Agent

A Targeted Nanoglobular Contrast Agent from Host-Guest Self-Assembly for MR Cancer Molecular Imaging.

Biological activity and magnetic resonance imaging of superparamagnetic iron oxide nanoparticles-labeled adipose-derived stem cells

Effective tracking of bone mesenchymal stem cells in vivo by magnetic resonance imaging using melanin-based gadolinium 3+ nanoparticles.

Tracking mesenchymal stromal cells using an ultra-bright TAT-functionalized plasmonic-active nanoplatform

Protamine functionalized single-walled carbon nanotubes for stem cell labeling and in vivo Raman/magnetic resonance/photoacoustic triple-modal imaging

Targeted Biodegradable Dendritic MRI Contrast Agent for Enhanced Tumor Imaging

A Dendritic Supramolecular Complex As Uniform Hybrid Micelle with Dual Structure for Bimodal in Vivo Imaging

Assessment of Biological Characteristics of Adipose Tissue-Derived Stem Cells Co-Labeled with Molday ION Rhodamine B™ and Green Fluorescent Protein in Vitro.

Multi-arm star-branched polymer as an efficient contrast agent for tumor-targeted magnetic resonance imaging

Development of an Aptamer-Conjugated Polyrotaxane-Based Biodegradable Magnetic Resonance Contrast Agent for Tumor-Targeted Imaging.

Gadolinium-Incorporated Carbon Nanodots for T 1 -Weighted Magnetic Resonance Imaging

Superparamagnetic Iron Oxide Nanoparticles-Complexed Cationic Amylose for In Vivo Magnetic Resonance Imaging Tracking of Transplanted Stem Cells in Stroke

MRI Reveals Slow Clearance of Dead Cell Transplants in Mouse Forelimb Muscles

Optimization of magnetosonoporation for stem cell labeling

Stimuli-responsive Biodegradable and Gadolinium-Based Poly[n-(2-hydroxypropyl) Methacrylamide] Copolymers: Their Potential As Targeting and Safe Magnetic Resonance Imaging Probes